Trade Theravance Biopharma, Inc. - TBPH CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02354% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001318% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9.62 |
| Open | 9.55 |
| 1-Year Change | -1.95% |
| Day's Range | 9.24 - 9.59 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 31, 2025 | 9.37 | -0.09 | -0.95% | 9.46 | 9.59 | 9.23 |
| Jan 30, 2025 | 9.62 | 0.18 | 1.91% | 9.44 | 9.74 | 9.44 |
| Jan 29, 2025 | 9.56 | -0.08 | -0.83% | 9.64 | 9.70 | 9.41 |
| Jan 28, 2025 | 9.74 | 0.09 | 0.93% | 9.65 | 9.83 | 9.54 |
| Jan 27, 2025 | 9.60 | -0.68 | -6.61% | 10.28 | 10.39 | 9.57 |
| Jan 24, 2025 | 10.44 | 1.13 | 12.14% | 9.31 | 10.84 | 9.23 |
| Jan 23, 2025 | 9.60 | 0.73 | 8.23% | 8.87 | 9.65 | 8.87 |
| Jan 22, 2025 | 9.29 | 0.34 | 3.80% | 8.95 | 9.39 | 8.87 |
| Jan 21, 2025 | 9.06 | 0.51 | 5.96% | 8.55 | 9.15 | 8.43 |
| Jan 17, 2025 | 8.49 | 0.06 | 0.71% | 8.43 | 8.55 | 8.34 |
| Jan 16, 2025 | 8.37 | -0.11 | -1.30% | 8.48 | 8.52 | 8.33 |
| Jan 15, 2025 | 8.57 | 0.07 | 0.82% | 8.50 | 8.82 | 8.40 |
| Jan 14, 2025 | 8.47 | -0.03 | -0.35% | 8.50 | 8.67 | 8.41 |
| Jan 13, 2025 | 8.54 | -0.02 | -0.23% | 8.56 | 8.67 | 8.49 |
| Jan 10, 2025 | 8.75 | -0.12 | -1.35% | 8.87 | 8.90 | 8.63 |
| Jan 8, 2025 | 9.00 | -0.23 | -2.49% | 9.23 | 9.30 | 8.95 |
| Jan 7, 2025 | 9.22 | 0.15 | 1.65% | 9.07 | 9.27 | 8.97 |
| Jan 6, 2025 | 9.14 | -0.14 | -1.51% | 9.28 | 9.39 | 9.09 |
| Jan 3, 2025 | 9.28 | 0.11 | 1.20% | 9.17 | 9.51 | 9.11 |
| Jan 2, 2025 | 9.21 | -0.13 | -1.39% | 9.34 | 9.41 | 9.18 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Theravance Biopharma, Inc. Company profile
About Theravance Biopharma Inc
Theravance Biopharma, Inc. is a diversified biopharmaceutical company, which is primarily focused on the discovery, development and commercialization of organ-selective medicines. The Company develops transformational medicines to improve the lives of patients suffering from serious illnesses. The Company's research is focused in the areas of inflammation and immunology. It applies organ-selective knowledge to biologically compelling targets to discover and develop medicines, which are designed to treat underserved localized diseases and to limit systemic exposure. The Company is developing lung-selective medicines to treat respiratory disease, including YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its revefenacin is a long-acting muscarinic antagonist (LAMA). Its programs also include Nezulcitinib, Ampreloxetine (TD-9855), Izencitinib, TD-5202 and TD-8236.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Theravance Biopharma Inc revenues decreased 23% to $55.3M. Net loss decreased 28% to $199.4M. Revenues reflect U.S. segment decrease of 21% to $55.3M, Europe segment decrease of 98% to $38K. Lower net loss reflects Research and development - bal decrease of 27% to $166.6M (expense), Selling, general and administrative -bal decrease of 55% to $31M (expense).
| Industry: | Pharmaceuticals (NEC) |
Ugland House, South Church Street
GEORGE TOWN
GRAND CAYMAN KY1-1104
KY
News
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com